The role of B cells in atherosclerosis (original) (raw)

• GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459–1544 (2016).
  Google Scholar
• Libby, P., Lichtman, A. H. & Hansson, G. K. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38, 1092–1104 (2013).
  CAS PubMed PubMed Central Google Scholar
• Gisterå, A. & Hansson, G. K. The immunology of atherosclerosis. Nat. Rev. Nephrol. 13, 368–380 (2017).
  PubMed Google Scholar
• Binder, C. J., Papac-Milicevic, N. & Witztum, J. L. Innate sensing of oxidation-specific epitopes in health and disease. Nat. Rev. Immunol. 16, 485–497 (2016).
  CAS PubMed Google Scholar
• Tsiantoulas, D., Diehl, C. J., Witztum, J. L. & Binder, C. J. B cells and humoral immunity in atherosclerosis. Circ. Res. 114, 1743–1756 (2014).
  CAS PubMed PubMed Central Google Scholar
• Yahagi, K. et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat. Rev. Cardiol. 13, 79–98 (2015).
  PubMed Google Scholar
• Hansson, G. K., Libby, P. & Tabas, I. Inflammation and plaque vulnerability. J. Intern. Med. 278, 483–493 (2015).
  CAS PubMed PubMed Central Google Scholar
• Houtkamp, M. A., de Boer, O. J., van der Loos, C. M., van der Wal, A. C. & Becker, A. E. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J. Pathol. 193, 263–269 (2001).
  CAS PubMed Google Scholar
• Moos, M. P. et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 2386–2391 (2005).
  CAS PubMed Google Scholar
• Smith, J. D. et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl Acad. Sci. USA 92, 8264–8268 (1995).
  CAS PubMed Google Scholar
• Song, L., Leung, C. & Schindler, C. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108, 251–259 (2001).
  CAS PubMed PubMed Central Google Scholar
• Reardon, C. A., Blachowicz, L., Lukens, J., Nissenbaum, M. & Getz, G. S. Genetic background selectively influences innominate artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 1449–1454 (2003).
  CAS PubMed Google Scholar
• Skaggs, B. J., Hahn, B. H. & McMahon, M. Accelerated atherosclerosis in patients with SLE—mechanisms and management. Nat. Rev. Rheumatol. 8, 214–223 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).
  CAS Google Scholar
• Tsiantoulas, D., Sage, A. P., Mallat, Z. & Binder, C. J. Targeting B cells in atherosclerosis: closing the gap from bench to bedside. Arterioscler. Thromb. Vasc. Biol. 35, 296–302 (2015).
  CAS PubMed Google Scholar
• Srikakulapu, P. & McNamara, C. B. Cells and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 312, H1060–H1067 (2017).
  PubMed PubMed Central Google Scholar
• Hardy, R. R., Kincade, P. W. & Dorshkind, K. The protean nature of cells in the B lymphocyte lineage. Immunity 26, 703–714 (2007).
  CAS PubMed Google Scholar
• Clark, M. R., Mandal, M., Ochiai, K. & Singh, H. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat. Rev. Immunol. 14, 69–80 (2014).
  CAS PubMed Google Scholar
• Schatz, D. G. & Ji, Y. Recombination centres and the orchestration of V(D)J recombination. Nat. Rev. Immunol. 11, 251–263 (2011).
  CAS PubMed Google Scholar
• Nimmerjahn, F. & Ravetch, J. V. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 310, 1510–1512 (2005).
  CAS PubMed Google Scholar
• Anthony, R. M., Wermeling, F. & Ravetch, J. V. Novel roles for the IgG Fc glycan. Ann. NY Acad. Sci. 1253, 170–180 (2012).
  CAS PubMed Google Scholar
• Menni, C. et al. Glycosylation profile of immunoglobulin G is cross-sectionally associated with cardiovascular disease risk score and subclinical atherosclerosis in two independent cohorts. Circ. Res. 122, 1555–1564 (2018).
  CAS PubMed PubMed Central Google Scholar
• Pillai, S. & Cariappa, A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9, 767–777 (2009).
  CAS PubMed Google Scholar
• Hardy, R. R. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr. Opin. Immunol. 18, 547–555 (2006).
  CAS PubMed Google Scholar
• Baumgarth, N. B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production. Front. Immunol. 7, 324 (2016).
  PubMed PubMed Central Google Scholar
• Choi, Y., Dieter, J. A., Rothaeusler, K., Luo, Z. & Baumgarth, N. B-1 cells in the bone marrow are a significant source of natural IgM. Eur. J. Immunol. 42, 120–129 (2012).
  CAS PubMed Google Scholar
• Griffin, D. O., Holodick, N. E. & Rothstein, T. L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−. J. Exp. Med. 208, 67–80 (2011).
  CAS PubMed PubMed Central Google Scholar
• Muppidi, J. R. et al. Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone. J. Exp. Med. 208, 1941–1948 (2011).
  CAS PubMed PubMed Central Google Scholar
• Weller, S. et al. Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104, 3647–3654 (2004).
  CAS PubMed PubMed Central Google Scholar
• Palm, A.-K. E., Friedrich, H. C. & Kleinau, S. Nodal marginal zone B cells in mice: a novel subset with dormant self-reactivity. Sci. Rep. 6, 27687 (2016).
  CAS PubMed PubMed Central Google Scholar
• Tas, J. M. J. et al. Visualizing antibody affinity maturation in germinal centers. Science 351, 1048–1054 (2016).
  CAS PubMed PubMed Central Google Scholar
• Corcoran, L. M. & Tarlinton, D. M. Regulation of germinal center responses, memory B cells and plasma cell formation-an update. Curr. Opin. Immunol. 39, 59–67 (2016).
  CAS PubMed Google Scholar
• Dogan, I. et al. Multiple layers of B cell memory with different effector functions. Nat. Immunol. 10, 1292–1299 (2009).
  CAS PubMed Google Scholar
• Weisel, F. J., Zuccarino-Catania, G. V., Chikina, M. & Shlomchik, M. J. A. Temporal switch in the germinal center determines differential output of memory B and plasma cells. Immunity 44, 116–130 (2016).
  CAS PubMed PubMed Central Google Scholar
• Reynolds, A. E., Kuraoka, M. & Kelsoe, G. Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow. J. Immunol. 194, 231–242 (2015).
  CAS PubMed Google Scholar
• Montecino-Rodriguez, E. et al. Distinct genetic networks orchestrate the emergence of specific waves of fetal and adult B-1 and B-2 development. Immunity 45, 527–539 (2016).
  CAS PubMed PubMed Central Google Scholar
• Tanigaki, K. et al. Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3, 443–450 (2002).
  CAS PubMed Google Scholar
• Goodnow, C. C., Sprent, J., Fazekas de St Groth, B. & Vinuesa, C. G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435, 590–597 (2005).
  CAS PubMed Google Scholar
• von Boehmer, H. & Melchers, F. Checkpoints in lymphocyte development and autoimmune disease. Nat. Immunol. 11, 14–20 (2009).
  Google Scholar
• Chan, T. D. et al. Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity 37, 893–904 (2012).
  CAS PubMed Google Scholar
• Malkiel, S., Barlev, A. N., Atisha-Fregoso, Y., Suurmond, J. & Diamond, B. Plasma cell differentiation pathways in systemic lupus erythematosus. Front. Immunol. 9, 427 (2018).
  PubMed PubMed Central Google Scholar
• Knoflach, M., Behard, D. & Wick, G. Anti-HSP60 immunity is already associated with atherosclerosis early in life. Ann. NY Acad. Sci. 1051, 323–331 (2005).
  CAS PubMed Google Scholar
• Grundtman, C. et al. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides. Atherosclerosis 242, 303–310 (2015).
  CAS PubMed Google Scholar
• Aprahamian, T. et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199, 1121–1131 (2004).
  CAS PubMed PubMed Central Google Scholar
• Feng, X. et al. ApoE−/−Fas−/− C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J. Lipid Res. 48, 794–805 (2007).
  CAS PubMed Google Scholar
• Gautier, E. L. et al. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler. Thromb. Vasc. Biol. 27, 1625–1631 (2007).
  CAS PubMed Google Scholar
• Stanic, A. K. et al. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 103, 7018–7023 (2006).
  CAS PubMed Google Scholar
• Lewis, M. J. et al. Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia. Arthritis Rheum. 64, 2707–2718 (2012).
  CAS PubMed PubMed Central Google Scholar
• Temmerman, L. et al. Leukocyte Bim deficiency does not impact atherogenesis in Ldlr −/− mice, despite a pronounced induction of autoimmune inflammation. Sci. Rep. 7, 3086 (2017).
  PubMed PubMed Central Google Scholar
• Konstantinov, I. E., Mejevoi, N. & Anichkov, N. M. Nikolai, N. Anichkov and his theory of atherosclerosis. Tex. Heart Inst. J. 33, 417–423 (2006).
  PubMed PubMed Central Google Scholar
• Libby, P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 2045–2051 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hollander, W., Colombo, M. A., Kirkpatrick, B. & Paddock, J. Soluble proteins in the human atheroschlerotic plaque with spectral reference to immunoglobulins, C3-complement component, α1-antitrypsin and α2-macroglobulin. Atherosclerosis 34, 391–405 (1979).
  CAS PubMed Google Scholar
• Hansson, G. K., Bondjers, G., Bylock, A. & Hjalmarsson, L. Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits. Exp. Mol. Pathol. 33, 302–315 (1980).
  CAS PubMed Google Scholar
• Parums, D. & Mitchinson, M. J. Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques. Atherosclerosis 38, 211–216 (1981).
  CAS PubMed Google Scholar
• Vlaicu, R., Rus, H. G., Niculescu, F. & Cristea, A. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 55, 35–50 (1985).
  CAS PubMed Google Scholar
• Ylä-Herttuala, S. et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 14, 32–40 (1994).
  Google Scholar
• Tsiantoulas, D. et al. Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J. Lipid Res. 56, 440–448 (2015).
  CAS PubMed PubMed Central Google Scholar
• Palinski, W. et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98, 800–814 (1996).
  CAS PubMed PubMed Central Google Scholar
• Boullier, A. et al. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 275, 9163–9169 (2000).
  CAS PubMed Google Scholar
• Friedman, P., Hörkkö, S., Steinberg, D., Witztum, J. L. & Dennis, E. A. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids: importance of schiff base formation and aldol condensation. J. Biol. Chem. 277, 7010–7020 (2002).
  CAS PubMed Google Scholar
• Hamze, M. et al. Characterization of resident B cells of vascular walls in human atherosclerotic patients. J. Immunol. 191, 3006–3016 (2013).
  CAS PubMed Google Scholar
• Winkels, H. et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ. Res. 122, 1675–1688 (2018).
  CAS PubMed Google Scholar
• Huan, T. et al. A systems biology framework identifies molecular underpinnings of coronary heart disease significance. Arterioscler. Thromb. Vasc. Biol. 33, 1427–1434 (2013).
  CAS PubMed PubMed Central Google Scholar
• Mantani, P. T. et al. Circulating CD40+ and CD86+ B cell subsets demonstrate opposing associations with risk of stroke. Arterioscler. Thromb. Vasc. Biol. 34, 211–218 (2014).
  CAS PubMed Google Scholar
• Meeuwsen, J. A. L. et al. High levels of (Un)switched memory B cells are associated with better outcome in patients with advanced atherosclerotic disease. J. Am. Heart Assoc. 6, e005747 (2017).
  PubMed PubMed Central Google Scholar
• Caligiuri, G., Nicoletti, A., Poirier, B. & Hansson, G. K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 745–753 (2002).
  CAS PubMed PubMed Central Google Scholar
• Major, A. S., Fazio, S. & Linton, M. F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 22, 1892–1898 (2002).
  CAS PubMed Google Scholar
• Muscari, A. et al. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 74, 179–186 (1988).
  CAS PubMed Google Scholar
• Hu, D. et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors. Immunity 42, 1100–1115 (2015).
  CAS PubMed PubMed Central Google Scholar
• Srikakulapu, P. et al. Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE−/− mice. Arterioscler. Thromb. Vasc. Biol. 36, 1174–1185 (2016).
  CAS PubMed PubMed Central Google Scholar
• Dunér, P. et al. Increased aldehyde-modification of collagen type IV in symptomatic plaques – a possible cause of endothelial dysfunction. Atherosclerosis 240, 26–32 (2015).
  PubMed Google Scholar
• Vallejo, J., Duner, P., Fredrikson, G. N., Nilsson, J. & Bengtsson, E. Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction. J. Intern. Med. 282, 496–507 (2017).
  CAS PubMed Google Scholar
• Engelbertsen, D. et al. Low levels of IgM antibodies against an advanced glycation endproduct-modified apolipoprotein B100 peptide predict cardiovascular events in nondiabetic subjects. J. Immunol. 195, 3020–3025 (2015).
  CAS PubMed Google Scholar
• Miller, Y. I. et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235–248 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kortelainen, M.-L. & Porvari, K. Adventitial macrophage and lymphocyte accumulation accompanying early stages of human coronary atherogenesis. Cardiovasc. Pathol. 23, 193–197 (2014).
  CAS PubMed Google Scholar
• Liang, K. P. et al. Autoantibodies and the risk of cardiovascular events. J. Rheumatol 36, 2462–2469 (2009).
  PubMed PubMed Central Google Scholar
• Cambridge, G., Acharya, J., Cooper, J. A., Edwards, J. C. & Humphries, S. E. Antibodies to citrullinated peptides and risk of coronary heart disease. Atherosclerosis 228, 243–246 (2013).
  CAS PubMed Google Scholar
• Huang, Y. et al. An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat. Med. 20, 193–203 (2014).
  CAS PubMed PubMed Central Google Scholar
• Montecucco, F. et al. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4. Thromb. Haemost. 114, 410–422 (2015).
  CAS PubMed Google Scholar
• Pagano, S. et al. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. J. Intern. Med. 272, 344–357 (2012).
  CAS PubMed Google Scholar
• George, J., Afek, A., Gilburd, B., Shoenfeld, Y. & Harats, D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 38, 900–905 (2001).
  CAS PubMed Google Scholar
• Merched, A. J., Daret, D., Li, L., Franzl, N. & Sauvage-Merched, M. Specific autoantigens in experimental autoimmunity-associated atherosclerosis. FASEB J. 30, 2123–2134 (2016).
  CAS PubMed Google Scholar
• Carroll, M. C. & Isenman, D. E. Regulation of humoral immunity by complement. Immunity 37, 199–207 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kubagawa, H. et al. Identity of the elusive IgM Fc receptor (FcμR) in humans. J. Exp. Med. 206, 2779–2793 (2009).
  CAS PubMed PubMed Central Google Scholar
• Brenner, D. et al. Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells. Proc. Natl Acad. Sci. USA 111, 1060–1065 (2014).
  CAS PubMed Google Scholar
• Tsiantoulas, D. et al. Secreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development. Sci. Rep. 7, 3540 (2017).
  PubMed PubMed Central Google Scholar
• Notley, C. A., Baker, N. & Ehrenstein, M. R. Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survival. J. Immunol. 184, 3386–3393 (2010).
  CAS PubMed Google Scholar
• Gonen, A. et al. Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine. J. Lipid Res. 55, 2137–2155 (2014).
  CAS PubMed PubMed Central Google Scholar
• Binder, C. J. et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114, 427–437 (2004).
  CAS PubMed PubMed Central Google Scholar
• Khoo, L., Thiam, C., Soh, S. & Angeli, V. Splenic extrafollicular reactions and BM plasma cells sustain IgM response associated with hypercholesterolemia. Eur. J. Immunol. 45, 1300–1312 (2015).
  CAS PubMed Google Scholar
• Chou, M.-Y. et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J. Clin. Invest. 119, 1335–1349 (2009).
  CAS PubMed PubMed Central Google Scholar
• Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155–161 (2009).
  PubMed PubMed Central Google Scholar
• Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235–249 (2007).
  Google Scholar
• Iseme, R. A. et al. A role for autoantibodies in atherogenesis. Cardiovasc. Res. 113, 1102–1112 (2017).
  CAS PubMed Google Scholar
• Shaw, P. X. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105, 1731–1740 (2000).
  CAS PubMed PubMed Central Google Scholar
• Binder, C. J. et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9, 736 (2003).
  CAS PubMed Google Scholar
• Faria-Neto, J. R. et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 189, 83–90 (2006).
  CAS PubMed Google Scholar
• Cesena, F. H. et al. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE−/− mice. Atherosclerosis 220, 59–65 (2012).
  CAS PubMed Google Scholar
• Busch, C. J. et al. Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice. Hepatology 65, 1181–1195 (2017).
  CAS PubMed PubMed Central Google Scholar
• Centa, M. et al. Atherosclerosis susceptibility in mice is independent of the V1 immunoglobulin heavy chain gene. Arterioscler. Thromb. Vasc. Biol. 36, 25–36 (2016).
  CAS PubMed Google Scholar
• Que, X. et al. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558, 301–306 (2018).
  CAS PubMed PubMed Central Google Scholar
• Gruber, S. et al. Sialic acid-binding immunoglobulin-like Lectin G promotes atherosclerosis and liver inflammation by suppressing the protective functions of B-1 cells. Cell Rep. 14, 2348–2361 (2016).
  CAS PubMed PubMed Central Google Scholar
• Grasset, E. K. et al. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B cell response. Proc. Natl Acad. Sci. USA 112, E2030–E2038 (2015).
  CAS PubMed Google Scholar
• Hosseini, H. et al. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes. Cardiovasc. Res. 106, 443–452 (2015).
  CAS PubMed Google Scholar
• Kyaw, T. et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ. Res. 109, 830–840 (2011).
  CAS PubMed Google Scholar
• Khamis, R. Y. et al. High serum immunoglobulin G and M levels predict freedom from adverse cardiovascular events in hypertension: a nested case-control substudy of the anglo-scandinavian cardiac outcomes trial. EBioMedicine 9, 372–380 (2016).
  PubMed PubMed Central Google Scholar
• Lewis, M. J. et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120, 417–426 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tsiantoulas, D. et al. Increased plasma IgE accelerate atherosclerosis in secreted IgM deficiency. Circ. Res. 120, 78–84 (2017).
  CAS PubMed Google Scholar
• Perry, H. M. et al. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation. Arterioscler. Thromb. Vasc. Biol. 33, 2771–2779 (2013).
  CAS PubMed PubMed Central Google Scholar
• Newland, S. A. et al. Type-2 innate lymphoid cells control the development of atherosclerosis in mice. Nat. Commun. 8, 15781 (2017).
  CAS PubMed PubMed Central Google Scholar
• Miller, A. M. et al. IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205, 339–346 (2008).
  CAS PubMed PubMed Central Google Scholar
• Martin, P. et al. Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immun. Inflamm. Dis. 3, 239–246 (2015).
  CAS PubMed PubMed Central Google Scholar
• Sämpi, M. et al. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J. Am. Coll. Cardiol. 52, 1370–1378 (2008).
  PubMed Google Scholar
• Engelbertsen, D. et al. T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler. Thromb. Vasc. Biol. 33, 637–644 (2013).
  CAS PubMed Google Scholar
• Sage, A. P. et al. X-box binding protein-1 dependent plasma cell responses limit the development of atherosclerosis. Circ. Res. 121, 270–281 (2017).
  CAS PubMed Google Scholar
• Rahman, M. et al. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: regulation and underlying mechanisms. Clin. Immunol. 166–167, 27–37 (2016).
  PubMed Google Scholar
• Engelbertsen, D. et al. Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE −/− mice. Cardiovasc. Res. 103, 304–312 (2014).
  CAS PubMed Google Scholar
• Gould, H. J. & Sutton, B. J. IgE in allergy and asthma today. Nat. Rev. Immunol. 8, 205–217 (2008).
  CAS PubMed Google Scholar
• Bot, I. et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E–deficient mice. Circulation 115, 2516–2525 (2007).
  CAS PubMed Google Scholar
• Sun, J. et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 13, 719–724 (2007).
  CAS PubMed Google Scholar
• Wezel, A. et al. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression. Atherosclerosis 241, 289–296 (2015).
  CAS PubMed Google Scholar
• Wang, K.-Y. et al. Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level. Arterioscler. Thromb. Vasc. Biol. 31, 800–807 (2011).
  CAS PubMed Google Scholar
• Wang, J. et al. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe −/− mice. J. Clin. Invest. 121, 3564–3577 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kalesnikoff, J. et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14, 801–811 (2001).
  CAS PubMed Google Scholar
• Pandey, V., Mihara, S., Fensome-Green, A., Bolsover, S. & Cockcroft, S. Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J. Immunol. 172, 4048–4058 (2004).
  CAS PubMed Google Scholar
• Prasad, A. et al. Relationship of autoantibodies to MDA-LDL and ApoB-immune complexes to sex, ethnicity, subclinical atherosclerosis, and cardiovascular events. Arterioscler. Thromb. Vasc. Biol. 37, 1213–1221 (2017).
  CAS PubMed PubMed Central Google Scholar
• Mayr, M. et al. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study. J. Am. Coll. Cardiol. 47, 2436–2443 (2006).
  CAS PubMed Google Scholar
• Nilsson, J. Can antibodies protect us against cardiovascular disease? EBioMedicine 9, 29–30 (2016).
  PubMed PubMed Central Google Scholar
• Saad, A. F., Virella, G., Chassereau, C., Boackle, R. J. & Lopes-Virella, M. F. OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages. J. Lipid Res. 47, 1975–1983 (2006).
  CAS PubMed Google Scholar
• Lennartz, M. R. et al. Ligation of macrophage Fcγ receptors recapitulates the gene expression pattern of vulnerable human carotid plaques. PLOS ONE 6, e21803 (2011).
  CAS PubMed PubMed Central Google Scholar
• Rhoads, J. P. et al. Oxidized low-density lipoprotein immune complex priming of the Nlrp3 inflammasome involves TLR and FcγR cooperation and is dependent on CARD9. J. Immunol. 198, 2105–2114 (2017).
  CAS PubMed PubMed Central Google Scholar
• Ravandi, A. et al. Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study. J. Lipid Res. 52, 1829–1836 (2011).
  CAS PubMed PubMed Central Google Scholar
• Schiopu, A. et al. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation 110, 2047–2052 (2004).
  CAS PubMed Google Scholar
• Klimov, A. N. et al. Lipoprotein-antibody immune complexes their catabolism and role in foam cell formation. Atherosclerosis 58, 1–15 (1985).
  CAS PubMed Google Scholar
• Jackson, S. W. et al. Cutting edge: BAFF overexpression reduces atherosclerosis via TACI-dependent B cell activation. J. Immunol. 197, 4529–4534 (2016).
  CAS PubMed PubMed Central Google Scholar
• Tsimikas, S. et al. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation 110, 1406–1412 (2004).
  CAS PubMed Google Scholar
• Palinski, W., Miller, E. & Witztum, J. L. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl Acad. Sci. USA 92, 821–825 (1995).
  CAS PubMed Google Scholar
• Freigang, S., Horkko, S., Miller, E., Witztum, J. L. & Palinski, W. Immunization of LDL receptor deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol. 18, 1972–1982 (1998).
  CAS PubMed Google Scholar
• Klingenberg, R. et al. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 946–952 (2010).
  CAS PubMed Google Scholar
• Herbin, O. et al. Regulatory T cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 32, 605–612 (2012).
  CAS PubMed Google Scholar
• Tay, C. et al. Follicular B cells promote atherosclerosis via T cell-mediated differentiation into plasma cells and secreting pathogenic immunoglobulin G. Arterioscler. Thromb. Vasc. Biol. 38, e71–e84 (2018).
  CAS PubMed Google Scholar
• Clement, M. et al. Control of the T follicular helper-germinal center B cell axis by CD8+ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation 131, 560–570 (2015).
  CAS PubMed Google Scholar
• Nus, M. et al. Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet. Nat. Med. 23, 601–610 (2017).
  CAS PubMed Google Scholar
• Gaddis, D. E. et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat. Commun. 9, 1095 (2018).
  PubMed PubMed Central Google Scholar
• Centa, M. et al. Acute loss of apolipoprotein E triggers an autoimmune response that accelerates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 38, e145–e158 (2018).
  CAS PubMed PubMed Central Google Scholar
• Kelly, J. A. et al. Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10. Cardiovasc. Res. 85, 224–231 (2010).
  CAS PubMed Google Scholar
• Zhu, X. et al. Scavenger receptor function of mouse Fcγ receptor III contributes to progression of atherosclerosis in apolipoprotein E hyperlipidemic mice. J. Immunol. 193, 2483–2495 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ng, H. P., Burris, R. L. & Nagarajan, S. Attenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells. J. Immunol. 187, 6082–6093 (2011).
  CAS PubMed Google Scholar
• Mallavia, B. et al. Gene deficiency in activating Fcγ receptors influences the macrophage phenotypic balance and reduces atherosclerosis in mice. PLOS ONE 8, e66754 (2013).
  CAS PubMed PubMed Central Google Scholar
• Clement, M. et al. Necrotic cell sensor Clec4e promotes a proatherogenic macrophage phenotype through activation of the unfolded protein response. Circulation 134, 1039–1051 (2016).
  CAS PubMed Google Scholar
• Smith, K. G. C. & Clatworthy, M. R. FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol. 10, 328–343 (2010).
  CAS PubMed PubMed Central Google Scholar
• Jonsson, S. et al. Identification of sequence variants influencing immunoglobulin levels. Nat. Genet. 49, 1182–1191 (2017).
  CAS PubMed Google Scholar
• Harmon, E. Y. et al. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcgammaRIIb−/− mice develop fibrous carotid plaques. J. Am. Heart Assoc. 3, e001232 (2014).
  PubMed PubMed Central Google Scholar
• Ait-Oufella, H. et al. B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207, 1579–1587 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kyaw, T. et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J. Immunol. 185, 4410–4419 (2010).
  CAS PubMed Google Scholar
• Kyaw, T. et al. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE−/− mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLOS ONE 7, e29371 (2012).
  CAS PubMed PubMed Central Google Scholar
• Sage, A. P. et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice—brief report. Arterioscler. Thromb. Vasc. Biol. 32, 1573–1576 (2012).
  CAS PubMed Google Scholar
• Ponnuswamy, P. et al. Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells. Sci. Rep. 7, 4111 (2017).
  PubMed PubMed Central Google Scholar
• Misumi, I. & Whitmire, J. K. B. Cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J. Immunol. 192, 1597–1608 (2014).
  CAS PubMed PubMed Central Google Scholar
• Zeng, Q. et al. B cells mediate chronic allograft rejection independently of antibody production. J. Clin. Invest. 124, 1052–1056 (2014).
  CAS PubMed PubMed Central Google Scholar
• Hilgendorf, I. et al. Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation 129, 1677–1687 (2014).
  CAS PubMed PubMed Central Google Scholar
• Clement, M. et al. Deletion of IRF8 (interferon regulatory factor 8)-dependent dendritic cells abrogates proatherogenic adaptive immunity. Circ. Res. 122, 813–820 (2018).
  CAS PubMed Google Scholar
• Allman, W. R. et al. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection. Proc. Natl Acad. Sci. USA 112, E4094–E4103 (2015).
  CAS PubMed Google Scholar
• Tay, C. et al. B cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation. Cardiovasc. Res. 111, 385–397 (2016).
  CAS PubMed Google Scholar
• Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607–612 (2015).
  CAS PubMed Google Scholar
• Gjurich, B. N., Taghavie-Moghadam, P. L., Ley, K. & Galkina, E. V. L-Selectin deficiency decreases aortic B1a and Breg subsets and promotes atherosclerosis. Thromb. Haemost. 112, 803–811 (2014).
  PubMed PubMed Central Google Scholar
• Sage, A. P. et al. Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice. Arterioscler. Thromb. Vasc. Biol. 35, 1770–1773 (2015).
  CAS PubMed Google Scholar
• Strom, A. C. et al. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb. Haemost. 114, 835–847 (2015).
  PubMed Google Scholar
• Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111–2114 (2001).
  CAS PubMed Google Scholar
• Chang, S. K., Arendt, B. K., Darce, J. R., Wu, X. & Jelinek, D. F. A role for BLyS in the activation of innate immune cells. Blood 108, 2687–2694 (2006).
  CAS PubMed PubMed Central Google Scholar
• Tsiantoulas, D. et al. BAFF neutralization aggravates atherosclerosis. Circulation https://doi.org/10.1161/CIRCULATIONAHA.117.032790 (2018).
  Article PubMed PubMed Central Google Scholar
• Yan, M. et al. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2, 638–643 (2001).
  CAS PubMed Google Scholar
• Bossen, C. et al. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 111, 1004–1012 (2008).
  CAS PubMed Google Scholar
• Mackay, F. & Schneider, P. Cracking the BAFF code. Nat. Rev. Immunol. 9, 491–502 (2009).
  CAS PubMed Google Scholar
• Castigli, E. et al. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl Acad. Sci. USA 101, 3903–3908 (2004).
  CAS PubMed Google Scholar
• McCarron, M. J., Park, P. & Fooksman, D. R. CD138 mediates selection of mature plasma cells by regulating their survival. Blood 129, 2749–2759 (2017).
  CAS PubMed PubMed Central Google Scholar
• Moens, S. J. et al. Impact of the B cell growth factor APRIL on the qualitative and immunological characteristics of atherosclerotic plaques. PLOS ONE 11, e0164690 (2016).
  Google Scholar
• Browning, J. L. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat. Rev. Drug Discov. 5, 564–576 (2006).
  CAS PubMed Google Scholar
• Sage, A. P. & Mallat, Z. Readapting the adaptive immune response – therapeutic strategies for atherosclerosis. Br. J. Pharmacol. 174, 3926–3939 (2017).
  CAS PubMed PubMed Central Google Scholar
• Ketelhuth, D. F. J. & Hansson, G. K. Modulation of autoimmunity and atherosclerosis – common targets and promising translational approaches against disease. Circ. J. 79, 924–933 (2015).
  CAS PubMed Google Scholar
• Scott, S. D. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin’s lymphoma. Cancer Pract. 6, 195–197 (1998).
  CAS PubMed Google Scholar
• Edwards, J. et al. Efficacy of B-cell–targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350, 2572–2581 (2004).
  CAS PubMed Google Scholar
• Uchida, J. et al. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor–dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. 199, 1659–1669 (2004).
  CAS PubMed PubMed Central Google Scholar
• Zouggari, Y. et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 19, 1273–1280 (2013).
  CAS PubMed PubMed Central Google Scholar
• Morris-Rosenfeld, S., Lipinski, M. J. & McNamara, C. A. Understanding the role of B cells in atherosclerosis: potential clinical implications. Expert Rev. Clin. Immunol. 10, 77–89 (2013).
  PubMed PubMed Central Google Scholar
• Novikova, D. S. et al. The effects of rituximab on lipids, arterial stiffness and carotid intima-media thickness in rheumatoid arthritis. J. Kor. Med. Sci. 31, 202–207 (2015).
  Google Scholar
• Kerekes, G. et al. Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis. Clin. Rheumatol. 28, 705–710 (2009).
  PubMed Google Scholar
• Manzi, S. et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann. Rheum. Dis. 71, 1833–1838 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hahn, B. Belimumab for systemic lupus erythematosus. N. Engl. J. Med. 368, 1528–1535 (2013).
  CAS PubMed Google Scholar
• Wallace, D. J. et al. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum. 61, 1168–1178 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tattersall, M. C. et al. Late-onset asthma predicts cardiovascular disease events: the Wisconsin Sleep Cohort. J. Am. Heart Assoc. 5, e003448 (2016).
  PubMed PubMed Central Google Scholar
• Tattersall, M. C. et al. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 35, 1520–1525 (2015).
  CAS PubMed PubMed Central Google Scholar
• Knoflach, M. et al. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY Studies. Arch. Intern. Med. 165, 2521–2526 (2005).
  PubMed Google Scholar
• Dema, B. et al. Immunoglobulin E plays an immunoregulatory role in lupus. J. Exp. Med. 211, 2159–2168 (2014).
  CAS PubMed PubMed Central Google Scholar
• Dema, B. et al. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLOS ONE 9, e90424 (2014).
  PubMed PubMed Central Google Scholar
• Schiopu, A. et al. Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1−/−/low-density lipoprotein receptor−/− mice. J. Am. Coll. Cardiol. 50, 2313–2318 (2007).
  CAS PubMed Google Scholar
• Poulsen, C. B. et al. Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions. Int. J. Cardiol. 215, 506–515 (2016).
  PubMed Google Scholar
• Lehrer-Graiwer, J. et al. FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase ii study of safety, tolerability, and anti-inflammatory activity. JACC Cardiovasc. Imag. 8, 493–494 (2015).
  Google Scholar
• Chyu, K.-Y., Dimayuga, P. C. & Shah, P. K. Vaccine against arteriosclerosis: an update. Ther. Adv. Vaccines 5, 39–47 (2017).
  PubMed PubMed Central Google Scholar
• Caligiuri, G. et al. Phosphorylcholine-targeting immunization reduces atherosclerosis. J. Am. Coll. Cardiol. 50, 540–546 (2007).
  CAS PubMed Google Scholar
• Ren, S. et al. Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis. Open Heart 2, e000247 (2015).
  PubMed PubMed Central Google Scholar
• Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M. & Corcoran, L. M. The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15, 160–171 (2015).
  CAS PubMed Google Scholar
• Taubenheim, N. et al. High rate of antibody secretion is not integral to plasma cell differentiation as revealed by XBP-1 deficiency. J. Immunol. 189, 3328–3338 (2012).
  CAS PubMed Google Scholar
• Bromage, E., Stephens, R. & Hassoun, L. The third dimension of ELISPOTs: quantifying antibody secretion from individual plasma cells. J. Immunol. Methods 346, 75–79 (2009).
  CAS PubMed Google Scholar
• Shi, W. et al. Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells. Nat. Immunol. 16, 663–673 (2015).
  CAS PubMed Google Scholar
• Chu, V. T. & Berek, C. The establishment of the plasma cell survival niche in the bone marrow. Immunol. Rev. 251, 177–188 (2013).
  PubMed Google Scholar
• Xiang, Z. et al. FcγRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol. 8, 419–429 (2007).
  CAS PubMed Google Scholar
• Doran, A. C. et al. B cell aortic homing and atheroprotection depend on Id3. Circ. Res. 110, e1–e12 (2012).
  CAS PubMed Google Scholar
• Kyaw, T. et al. BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE−/− mice. PLOS ONE 8, e60430 (2013).
  CAS PubMed PubMed Central Google Scholar
• Rosenfeld, S. M. et al. B-1b cells secrete atheroprotective IgM and attenuate atherosclerosis. Circ. Res. 117, e28–e39 (2015).
  CAS PubMed PubMed Central Google Scholar
• Meiler, S. et al. Constitutive GITR activation reduces atherosclerosis by promoting regulatory CD4+ T-cell responses-brief report. Arterioscler. Thromb. Vasc. Biol. 36, 1748–1752 (2016).
  CAS PubMed Google Scholar
• Karvonen, J., Päivänsalo, M., Kesäniemi, A. Y. & Hörkkö, S. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108, 2107–2112 (2003).
  CAS PubMed Google Scholar
• Wilson, P. W. F. et al. Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study. Atherosclerosis 189, 364–368 (2006).
  CAS PubMed Google Scholar
• Bjorkbacka, H. et al. Low levels of apolipoprotein B-100 autoantibodies are associated with increased risk of coronary events. Arterioscler. Thromb. Vasc. Biol. 36, 765–771 (2016).
  PubMed Google Scholar
• Tsimikas, S. et al. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering. Arterioscler. Thromb. Vasc. Biol. 27, 175–181 (2007).
  CAS PubMed Google Scholar
• Fredrikson, G. N. et al. Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. Stroke 38, 1495–1500 (2007).
  CAS PubMed Google Scholar
• Kankaanpaa, J. et al. IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk. Atherosclerosis 269, 294–300 (2018).
  CAS PubMed Google Scholar
• de Faire, U. et al. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism. J. Autoimmun. 34, 73–79 (2010).
  PubMed Google Scholar
• Caidahl, K. et al. IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes. Int. J. Cardiol. 167, 464–469 (2013).
  PubMed Google Scholar
• Imhof, A. et al. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease. Atherosclerosis 243, 414–420 (2015).
  CAS PubMed Google Scholar
• Anania, C. et al. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus. Arthrit. Res. Ther. 12, 1–8 (2010).
  Google Scholar
• Fernández-Gutiérrez, B. et al. Cardiovascular disease in immune-mediated inflammatory diseases: a cross-sectional analysis of 6 cohorts. Medicine 96, e7308 (2017).
  PubMed PubMed Central Google Scholar
• Berendsen, M. L. T. et al. Anticyclic citrullinated peptide antibodies and rheumatoid factor as risk factors for 10-year cardiovascular morbidity in patients with rheumatoid arthritis: a large inception cohort study. J. Rheumatol 44, 1325–1330 (2017).
  CAS PubMed Google Scholar
• Antiochos, P. et al. Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IgG-related coronary artery disease prediction in the general population. Arterioscler. Thromb. Vasc. Biol. 37, 2342–2349 (2017).
  CAS PubMed Google Scholar
• Kounis, N. G. & Hahalis, G. Serum IgE levels in coronary artery disease. Atherosclerosis 251, 498–500 (2016).
  CAS PubMed Google Scholar
• Lippi, G., Cervellin, G. & Sanchis-Gomar, F. Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg? Ann. Med. 46, 456–463 (2014).
  CAS PubMed Google Scholar